Quality by design approach to the development of metformin hydrochloride granules with immediate and prolonged release
Macedonian Journal of Chemistry and Chemical Engineering · 23.06.2026 · 45 (1)
DOI: 10.20450/mjcce.2026.3471 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macedonian Journal of Chemistry and Chemical Engineering, online erschienen am 23.06.2026. Verfasst von Maja Todeska und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Metformin hydrochloride (MHCl) is administered at high doses and requires robust formulation strategies to balance rapid drug availability with controlled-release performance. This study applied a Quality by Design (QbD) framework to develop immediate-release (IR) and prolonged-release (PR) MHCl granules and to evaluate the impact of binder selection on product quality and release behavior. Formulations were produced via wet granulation using polyvinylpyrrolidone (PVP), gelatin, and pregelatinized starch 1500 as binders. PR granules were further coated with Eudragit® RS/RL using a fluid-bed process. Risk assessment tools (Ishikawa and FMECA) guided the identification of critical quality attributes (CQAs), critical material attributes (CMAs), and critical process parameters (CPPs). Compatibility studies confirmed the absence of drug–excipient interactions. All IR formulations demonstrated rapid dissolution (> 90% release within 5 min). Uncoated PR granules exhibited partial release control, while coated formulations showed binder-dependent differences in particle size distribution and dissolution performance. The gelatin-based PR formulation provided the most consistent release profile and the closest alignment with United States Pharmacopeia (USP) extended-release criteria, as it demonstrated low variability and minimal intermediate-point deviations. The study confirmed that binder selection was a high-impact critical material attribute for achieving robust prolonged-release MHCl granules within a QbD-driven development strategy.
Zitieren
APA
Todeska, M., Velickovski, D., Gjorgjevska, M., Petrushevska, D., Tasevska, T., Trpeska, L. L., Geskovski, N., Goracinova, K., Atanasovska, E., & Crcarevska, M. S. (2026). Quality by design approach to the development of metformin hydrochloride granules with immediate and prolonged release. Macedonian Journal of Chemistry and Chemical Engineering, 45(1). https://doi.org/10.20450/mjcce.2026.3471
Vancouver
Todeska M, Velickovski D, Gjorgjevska M, Petrushevska D, Tasevska T, Trpeska LL, et al. Quality by design approach to the development of metformin hydrochloride granules with immediate and prolonged release. Macedonian Journal of Chemistry and Chemical Engineering. 2026;45(1). doi:10.20450/mjcce.2026.3471
BibTeX
@article{Todeska2026,
author = {Todeska, Maja and Velickovski, Daniel and Gjorgjevska, Martina and Petrushevska, Dragana and Tasevska, Teodora and Trpeska, Lina Livrinska and Geskovski, Nikola and Goracinova, Katerina and Atanasovska, Emilija and Crcarevska, Maja Simonoska},
title = {Quality by design approach to the development of metformin hydrochloride granules with immediate and prolonged release},
journal = {Macedonian Journal of Chemistry and Chemical Engineering},
year = {2026},
volume = {45},
number = {1},
doi = {10.20450/mjcce.2026.3471}
}
EUVIMED